In breast cancer, loss of C/EBPβ was reported to promote breast cancer progression by shifting TGFβ response [40], which is an extremely strong stimulator of VEGF production by synovial fibroblasts [41, 42]. The gene discussed is VEGFA; the disease is breast carcinoma.